RTO | Rentokil InitialNYSEADR golden cross and death cross projections, cross tests and history

$23.57
-$0.50 (-2.08%)

Rentokil Initial (RTO) is a NYSE-listed ADR that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat below the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $23.57 vs 50 $21.89 / 200 $28.34
Projection
No cross projected
Test
No active test
Last cross
Death cross 21 Jul 2026 ยท projected 26 bars out ยท tested 1 bar

Weekly as of 30 Oct 16:00 ET

Price
below both $23.32 vs 50 $28.50 / 200 $28.93
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross week of 14 Sep 2026 ยท projected 12 bars out

4-hour as of 3 Nov 13:30 ET

Price
between the two $23.80 vs 50 $21.29 / 200 $24.75
Projection
No cross projected
Test
No active test
Last cross
Death cross 4 Jun 2026 ยท projected 29 bars out

Cross history

16
crosses on record since 2023
7 golden9 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
week of 14 Sep 2026Death flatweekly12 bars outActive Cross Test
21 Jul 2026Death steepdaily26 bars out1 bar cross test
4 Jun 2026Death4-hour29 bars outNot tested
4 Sep 2025Golden flatdaily14 bars outNot tested
5 Jun 2025Golden4-hour6 bars outโ€”

About RTO

ExchangeNYSE
InstrumentADR
Median $ volume, 60 d$36.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.